PGGM Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

PGGM Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$2.94M	Hold	23,112	–	–	0.01%	320
2021 Q4	$2.94M	Sell	23,112 -19,267	-45%	-$2.53M	0.01%	320
2021 Q3	$5.52M	Sell	42,379 -85,246	-67%	-$12.9M	0.03%	303
2021 Q2	$22.7M	Sell	127,625 -10,488	-8%	-$1.82M	0.1%	200
2021 Q1	$22.7M	Sell	138,113 -23,275	-14%	-$3.83M	0.1%	204
2020 Q4	$26.6M	Sell	161,388 -29,899	-16%	-$4.45M	0.12%	188
2020 Q3	$27.3M	Buy	191,287 +18,094	+10%	+$2.24M	0.14%	168
2020 Q2	$19.1M	Buy	173,193 +22,975	+15%	+$2.54M	0.11%	190
2020 Q1	$15M	Hold	150,218	–	–	0.11%	181
2019 Q4	$22.4M	Sell	150,218 -64,643	-30%	-$8.8M	0.13%	164
2019 Q3	$27.5M	Buy	214,861 +163,751	+320%	+$22M	0.13%	167
2019 Q2	$7.29M	Hold	51,110	–	–	0.04%	211
2019 Q1	$7.31M	Hold	51,110	–	–	0.04%	221
2018 Q4	$6.34M	Hold	51,110	–	–	0.04%	230
2018 Q3	$8.59M	Buy	+51,110	New	+$8.79M	0.05%	236
2015 Q4	–	Sell	-12,293	Closed	-$1.63M	–	387
2015 Q3	$1.63M	Sell	12,293 -212	-2%	-$36.5K	0.01%	370
2015 Q2	$2.2M	Buy	+12,505	New	+$2.25M	0.01%	373

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

PGGM Investments's JAZZ Position: Q1 2022 in Review

PGGM Investments held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2022 at 23,112 shares worth $2.94M. The position accounts for 0.01% of the portfolio, ranked #320.

PGGM Investments first reported a position in JAZZ in Q2 2015 and has held it in 17 quarters since. The position peaked at $27.5M in Q3 2019. 462 funds tracked by Wall St. Rank hold JAZZ as of Q1 2022.

PGGM Investments held 23,112 shares of Jazz Pharmaceuticals worth $2.94M as of Q1 2022.
PGGM Investments left its Jazz Pharmaceuticals share count unchanged in Q1 2022.
Jazz Pharmaceuticals made up 0.01% of PGGM Investments's portfolio in Q1 2022, its #320 holding.
PGGM Investments first reported a position in Jazz Pharmaceuticals in Q2 2015 and has held it in 17 quarters since.
PGGM Investments's Jazz Pharmaceuticals position peaked at $27.5M in Q3 2019.
462 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2022.

Based on PGGM Investments's 13F filing for Q1 2022, filed 25 Apr 2022.